Cargando…
Cervical cancer screening in Sweden 2014-2016
BACKGROUND: To enable incremental optimization of screening, regular reporting of quality indicators is required. AIM: To report key quality indicators and basic statistics about cervical screening in Sweden. METHODS: We collected individual level data on all cervical cytologies, histopathologies, h...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296530/ https://www.ncbi.nlm.nih.gov/pubmed/30557367 http://dx.doi.org/10.1371/journal.pone.0209003 |
_version_ | 1783381052323004416 |
---|---|
author | Hortlund, Maria Elfström, K. Miriam Sparén, Pär Almstedt, Pouran Strander, Björn Dillner, Joakim |
author_facet | Hortlund, Maria Elfström, K. Miriam Sparén, Pär Almstedt, Pouran Strander, Björn Dillner, Joakim |
author_sort | Hortlund, Maria |
collection | PubMed |
description | BACKGROUND: To enable incremental optimization of screening, regular reporting of quality indicators is required. AIM: To report key quality indicators and basic statistics about cervical screening in Sweden. METHODS: We collected individual level data on all cervical cytologies, histopathologies, human papillomavirus tests and all invitations for cervical screening in Sweden during 2013–2016. RESULTS: There were over 2,278,000 cervical samples collected in Sweden in 2014–2016. Organized samples (resulting from an invitation) constituted 69% of samples. The screening test coverage of all resident women aged 23–60 was 82%. The coverage has slowly increased for >10 years. There is large variability between counties (from 71% to 92%) over time. There were 25,725 women with high-grade lesions in cytology during 2013–2015. Only 96% of these women had a follow-up histopathology within a year. Cervical cancer incidence showed an increasing trend. CONCLUSION: Key quality indicators such as population coverage and follow-up rates were stable or improving, but there was nevertheless an unexplained cervical cancer increase. |
format | Online Article Text |
id | pubmed-6296530 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-62965302018-12-28 Cervical cancer screening in Sweden 2014-2016 Hortlund, Maria Elfström, K. Miriam Sparén, Pär Almstedt, Pouran Strander, Björn Dillner, Joakim PLoS One Research Article BACKGROUND: To enable incremental optimization of screening, regular reporting of quality indicators is required. AIM: To report key quality indicators and basic statistics about cervical screening in Sweden. METHODS: We collected individual level data on all cervical cytologies, histopathologies, human papillomavirus tests and all invitations for cervical screening in Sweden during 2013–2016. RESULTS: There were over 2,278,000 cervical samples collected in Sweden in 2014–2016. Organized samples (resulting from an invitation) constituted 69% of samples. The screening test coverage of all resident women aged 23–60 was 82%. The coverage has slowly increased for >10 years. There is large variability between counties (from 71% to 92%) over time. There were 25,725 women with high-grade lesions in cytology during 2013–2015. Only 96% of these women had a follow-up histopathology within a year. Cervical cancer incidence showed an increasing trend. CONCLUSION: Key quality indicators such as population coverage and follow-up rates were stable or improving, but there was nevertheless an unexplained cervical cancer increase. Public Library of Science 2018-12-17 /pmc/articles/PMC6296530/ /pubmed/30557367 http://dx.doi.org/10.1371/journal.pone.0209003 Text en © 2018 Hortlund et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Hortlund, Maria Elfström, K. Miriam Sparén, Pär Almstedt, Pouran Strander, Björn Dillner, Joakim Cervical cancer screening in Sweden 2014-2016 |
title | Cervical cancer screening in Sweden 2014-2016 |
title_full | Cervical cancer screening in Sweden 2014-2016 |
title_fullStr | Cervical cancer screening in Sweden 2014-2016 |
title_full_unstemmed | Cervical cancer screening in Sweden 2014-2016 |
title_short | Cervical cancer screening in Sweden 2014-2016 |
title_sort | cervical cancer screening in sweden 2014-2016 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296530/ https://www.ncbi.nlm.nih.gov/pubmed/30557367 http://dx.doi.org/10.1371/journal.pone.0209003 |
work_keys_str_mv | AT hortlundmaria cervicalcancerscreeninginsweden20142016 AT elfstromkmiriam cervicalcancerscreeninginsweden20142016 AT sparenpar cervicalcancerscreeninginsweden20142016 AT almstedtpouran cervicalcancerscreeninginsweden20142016 AT stranderbjorn cervicalcancerscreeninginsweden20142016 AT dillnerjoakim cervicalcancerscreeninginsweden20142016 |